29 participants
Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-14
- Start Date:
- 2012-10-16
- Completion:
- 2014-10-13
Conditions
- CLDN18.2-positive Gastric Adenocarcinoma
- CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction
- CLDN18.2-positive Adenocarcinoma of Esophagus
Interventions
- DRUG
No Results Yet